Ocata Therapeutics, Inc.
(NASDAQ : ACTC)

( )
ACTC After-Hours: () as of PM
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield

Message Boards

...

News

...
Health Technology » Pharmaceuticals Major

Company Profile

Ocata Therapeutics, Inc. engages in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine. The company also have a preclinical development pipeline in areas outside of ophthalmology, including; autoimmune diseases, inflammatory diseases, and wound healing. Ocata Therapeutics was founded on May 18, 2000 and is headquartered in Marlborough, MA.